Mitochondrial DNA release and inflammation in mitochondrial disease pathogenesis
Brain · 03.06.2026 · 149 (6) · 1874-1884
DOI: 10.1093/brain/awag037 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain, online erschienen am 02.02.2026. Verfasst von Marton Szabo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, University of Cambridge, Cambridge CP2 0PY, UK. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Mitochondrial Diseases, Inflammation, Mitochondria. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Discovery, Medical Research Council, Hereditary Neuropathy Foundation.
Abstract (Originalsprache)
Primary mitochondrial diseases (PMDs) affect ∼1 in 4300 individuals, yet mitochondrial dysfunction is also a hallmark of common inherited and acquired disorders. Although advances in genomics now allow molecular diagnosis in the majority of mitochondrial diseases, treatment remains largely supportive, leading to progressive disability and early mortality. Despite progress in gene-modifying approaches, no approved therapies exist for the majority of mitochondrial diseases, and none of the recent trials has met its primary end point, underlining the urgent need for innovative therapeutic strategies. Patients with PMDs have highly variable phenotypes, further complicated by increased susceptibility to infections, chronic inflammation and metabolic abnormalities. Recently, it has become evident that certain mitochondrial pathologies, including the loss of mitochondrial membrane integrity, impaired mitochondrial DNA (mtDNA) maintenance, quality control defects or respiratory chain defects, result in the release of mtDNA into the cytosol. Infections or metabolic changes also trigger the release of mtDNA, leading to the activation of a sterile innate immune response and interferon signalling. Free mtDNA acts as a pathogen-associated molecular pattern (PAMP), activating innate immune pathways such as the cGAS–STING axis, initiating a sterile inflammatory response. This can be followed by the extracellular release of mtDNA to convey the inflammatory response systemically to communicate between cells or across organs. However, it is unclear whether these pathways worsen the disease phenotype (hyperinflammatory reaction) or, in contrast, rescue the symptoms owing to upregulation of compensatory pathways. In this review, we summarize recent advances in understanding the mechanism of mtDNA release and how it activates innate immune signalling in PMDs. We also discuss the implications for pathogenesis, clinical phenotypes and therapeutic development. Defining the role of circulating mitochondrial material as a biomarker or therapeutic target is a crucial step for precision medicine approaches in PMDs. These pathways might also have wider implications for common metabolic, inflammatory and neurodegenerative disorders with mitochondrial dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Neurosciences, University of Cambridge, Cambridge CP2 0PY, UK.
ORCID-Profile: Daniel Lagos, Rita Horvath
Förderung
- Wellcome Discovery
- Medical Research Council
- Hereditary Neuropathy Foundation
- AFM-Telethon
- Ataxia UK
- Action for AT
- Muscular Dystrophy UK
- Rosetrees Trust
Zitieren
APA
Szabo, M., Lagos, D., Cross, E., Collier, J. J., & Horvath, R. (2026). Mitochondrial DNA release and inflammation in mitochondrial disease pathogenesis. Brain, 149(6), 1874-1884. https://doi.org/10.1093/brain/awag037
Vancouver
Szabo M, Lagos D, Cross E, Collier JJ, Horvath R. Mitochondrial DNA release and inflammation in mitochondrial disease pathogenesis. Brain. 2026;149(6):1874-1884. doi:10.1093/brain/awag037
BibTeX
@article{Szabo2026,
author = {Szabo, Marton and Lagos, Daniel and Cross, Emily and Collier, Jack J and Horvath, Rita},
title = {Mitochondrial DNA release and inflammation in mitochondrial disease pathogenesis},
journal = {Brain},
year = {2026},
volume = {149},
number = {6},
pages = {1874--1884},
doi = {10.1093/brain/awag037}
}
EUVIMED